The case for tumour-agnostic reimbursement of dual immunotherapy.
Saved in:
| Title: | The case for tumour-agnostic reimbursement of dual immunotherapy. |
|---|---|
| Authors: | Subbiah V; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: viveksubbiah@outlook.com., Kurzrock R; Center for Precision Oncology and Rare Cancers at Medical College of Wisconsin Cancer Center, Milwaukee, WI, USA; WIN Consortium, Paris, France. |
| Source: | European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 Jun 18; Vol. 241, pp. 116784. Date of Electronic Publication: 2026 May 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42106259 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The case for tumour-agnostic reimbursement of dual immunotherapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Subbiah+V%22">Subbiah V</searchLink>; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: viveksubbiah@outlook.com.<br /><searchLink fieldCode="AU" term="%22Kurzrock+R%22">Kurzrock R</searchLink>; Center for Precision Oncology and Rare Cancers at Medical College of Wisconsin Cancer Center, Milwaukee, WI, USA; WIN Consortium, Paris, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2026 Jun 18; Vol. 241, pp. 116784. <i>Date of Electronic Publication: </i>2026 May 05. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42106259 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ejca.2026.116784 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 116784 Titles: – TitleFull: The case for tumour-agnostic reimbursement of dual immunotherapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Subbiah V – PersonEntity: Name: NameFull: Kurzrock R IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 06 Text: 2026 Jun 18 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1879-0852 Numbering: – Type: volume Value: 241 Titles: – TitleFull: European journal of cancer (Oxford, England : 1990) Type: main |
| ResultId | 1 |